TW246675B - - Google Patents

Info

Publication number
TW246675B
TW246675B TW082106640A TW82106640A TW246675B TW 246675 B TW246675 B TW 246675B TW 082106640 A TW082106640 A TW 082106640A TW 82106640 A TW82106640 A TW 82106640A TW 246675 B TW246675 B TW 246675B
Authority
TW
Taiwan
Application number
TW082106640A
Other languages
Chinese (zh)
Original Assignee
Ciba Gerigy Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Gerigy Corp filed Critical Ciba Gerigy Corp
Application granted granted Critical
Publication of TW246675B publication Critical patent/TW246675B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6524Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW082106640A 1992-09-03 1993-08-18 TW246675B (OSRAM)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/940,118 US5273990A (en) 1992-09-03 1992-09-03 Phosphono substituted tetrazole derivatives

Publications (1)

Publication Number Publication Date
TW246675B true TW246675B (OSRAM) 1995-05-01

Family

ID=25474265

Family Applications (1)

Application Number Title Priority Date Filing Date
TW082106640A TW246675B (OSRAM) 1992-09-03 1993-08-18

Country Status (3)

Country Link
US (1) US5273990A (OSRAM)
TW (1) TW246675B (OSRAM)
ZA (1) ZA936434B (OSRAM)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP950558A2 (en) * 1994-11-15 1997-12-31 Scott M. Wilhelm Substituted 4-biarylbutric or biarylpentanoic acids and derivatives as matrix metalloprotease inhibitors
US5583123A (en) * 1994-12-22 1996-12-10 Ciba-Geigy Corporation Certain tetrazole derivatives
US5550119A (en) * 1995-03-02 1996-08-27 Ciba-Geigy Corporation Phosphono substituted tetrazole derivatives as ECE inhibitors
EP0821670A1 (en) * 1995-04-21 1998-02-04 Novartis AG N-aroylamino acid amides as endothelin inhibitors
US7468390B2 (en) * 2002-01-17 2008-12-23 Novartis Ag Methods of treatment and pharmaceutical composition
AU2003265398A1 (en) * 2002-08-09 2004-02-25 Transtech Pharma, Inc. Aryl and heteroaryl compounds and methods to modulate coagulation
US7208601B2 (en) * 2003-08-08 2007-04-24 Mjalli Adnan M M Aryl and heteroaryl compounds, compositions, and methods of use
US7459472B2 (en) * 2003-08-08 2008-12-02 Transtech Pharma, Inc. Aryl and heteroaryl compounds, compositions, and methods of use
AR057882A1 (es) * 2005-11-09 2007-12-26 Novartis Ag Compuestos de accion doble de bloqueadores del receptor de angiotensina e inhibidores de endopeptidasa neutra
KR101580067B1 (ko) 2007-01-12 2015-12-23 노파르티스 아게 5-바이페닐-4-아미노-2-메틸 펜탄산의 제조 방법
US20110015158A1 (en) 2007-12-11 2011-01-20 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
BRPI1011657A2 (pt) * 2009-05-28 2019-04-16 Novartis Ag derivados aminopropiônicos substituídos como inibidores de neprilisina
KR20120041702A (ko) * 2009-05-28 2012-05-02 노파르티스 아게 네프릴리신 억제제로서의 치환된 아미노부티르산 유도체
JO2967B1 (en) 2009-11-20 2016-03-15 نوفارتس ايه جي Acetic acid derivatives of carbamoyl methyl amino are substituted as new NEP inhibitors
KR101476937B1 (ko) 2010-08-23 2014-12-24 노파르티스 아게 Nep 억제제의 제조를 위한 중간체의 제조 방법
DK2887961T3 (da) 2012-08-24 2021-07-19 Novartis Ag Nep-inhibitorer til behandling af sygdomme, der er kendetegnet ved atrieforstørrelse eller -remodellering
NZ710574A (en) 2013-02-14 2017-11-24 Novartis Ag Substituted bisphenyl butanoic phosphonic acid derivatives as nep (neutral endopeptidase) inhibitors
KR20150119107A (ko) 2013-02-14 2015-10-23 노파르티스 아게 개선된 생체내 효능을 갖는 nep 억제제로서의 치환된 비스페닐 부탄산 유도체
WO2017033128A1 (en) 2015-08-25 2017-03-02 Novartis Ag Biphenyl-substitued 4-amino-butyric acid derivatives and their use in the synthesis of nep inhibitors
US20180311241A1 (en) 2015-10-29 2018-11-01 Cadila Healthcare Limited Pharmaceutical synergistic combination
UY38072A (es) 2018-02-07 2019-10-01 Novartis Ag Compuestos derivados de éster butanoico sustituido con bisfenilo como inhibidores de nep, composiciones y combinaciones de los mismos

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CY1406A (en) * 1980-12-18 1988-04-22 Schering Corp Substituted dipeptides, processes for their preparation and pharmaceutical compositions containing them and their use in the inhibition of enkephalinase
US4939261A (en) * 1984-06-08 1990-07-03 Ciba-Geigy Corporation N-substituted butyramide derivatives useful for treatment of conditions responsive to inhibition of enkephalinase
EP0225292A3 (en) * 1985-12-06 1988-11-30 Ciba-Geigy Ag Certain n-substituted butyramide derivatives
US5155100A (en) * 1991-05-01 1992-10-13 Ciba-Geigy Corporation Phosphono/biaryl substituted dipeptide derivatives

Also Published As

Publication number Publication date
ZA936434B (en) 1994-03-09
US5273990A (en) 1993-12-28

Similar Documents

Publication Publication Date Title
TW235354B (OSRAM)
DK0598561T3 (OSRAM)
TW232029B (OSRAM)
EP0601889A3 (OSRAM)
EP0554083A3 (OSRAM)
FR04C0024I2 (OSRAM)
DK0553875T3 (OSRAM)
TW221315B (OSRAM)
TW246675B (OSRAM)
TW223182B (OSRAM)
DK0599160T3 (OSRAM)
TW239232B (OSRAM)
DK0574087T3 (OSRAM)
DK0596750T3 (OSRAM)
DK0632741T3 (OSRAM)
DK135092A (OSRAM)
TW245638B (OSRAM)
DK0571874T3 (OSRAM)
DK0574276T3 (OSRAM)
FR2687417B1 (OSRAM)
DK0648175T3 (OSRAM)
FR2686427B1 (OSRAM)
DK0596569T3 (OSRAM)
TW221421B (OSRAM)
TW232044B (OSRAM)